INTEGRIS-PSC featured in an oral late breaker presentation SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- ...

Pliant Therapeutics, Inc. ( (PLRX) ) has released its Q3 earnings. Here is a breakdown of the information Pliant Therapeutics, Inc. presented ...

Leerink Partners analyst Faisal Khurshid reiterated a Buy rating on Pliant Therapeutics (PLRX – Research Report) yesterday and set a price ...

Senate won’t confirm, say, Matt Gaetz as attorney general? Just wait until they leave — maybe even if they don’t want to.

Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage clinical biotechnology company and leader in the discovery and development of novel therapeutics for the ...

SOUTH SAN FRANCISCO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: PLRX), today announced that Keith Cummings, M.D., Chief ...

Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have earned an average recommendation of “Buy” from the nine analysts that are covering the firm, Marketbeat Ratings reports. Eight ...

Royal scions and BJP leaders have sharply criticized Rahul Gandhi for his recent comments on the role of princely states ...

Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage clinical biotechnology company and leader in the discovery and development of novel therapeutics for the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...